Integrated Multi-Omics and Experimental Validation Identify a Spermidine-Responsive FREM1 Remodeling Program in Ischemic Heart Failure
- 1Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China
Abstract
Ischemic injury drives a sustained myocardial response in which metabolic stress, fibroblast activation, and extracellular-matrix remodeling converge to cause heart failure, yet the cell-resolved programs linking polyamine homeostasis to post-ischemic remodeling and the response to spermidine remain unclear. In this study, we integrated disease-burden estimates with bulk and single-nucleus myocardial transcriptomics, prioritizing polyamine-related genes by differential-expression analysis, gene-set scoring, and machine learning, followed by pathway, immune, cell–cell communication, and regulatory-network analyses, and evaluated spermidine in a post-myocardial-infarction mouse model using 8-week-old male C57BL/6J mice, with fibroblast-directed FREM1 activation to test whether FREM1 modifies the treatment response. Cross-platform analysis identified FREM1, MYH6, ARRDC3, and XAF1 as reproducible components of the ischemic-failing-heart signature, with FREM1 showing the strongest discrimination in the independent cohort; the program localized predominantly to fibroblasts and was linked to extracellular-matrix, inflammatory, and intercellular-signaling states. In mice, spermidine improved systolic function, reduced collagen deposition, shifted MTA and ornithine signals toward the sham pattern, and lowered myocardial FREM1; FREM1 activation weakened these effects, though residual benefit remained. These findings identify a fibroblast-enriched, spermidine-responsive FREM1 remodeling program linking polyamine-associated stress to post-ischemic fibrosis, positioning FREM1 as a candidate regulator of the cardiac response to spermidine and a potential entry point for therapeutic stratification in ischemic heart failure.
Related
- Integrated bulk and single-cell transcriptomic analyses with experimental validation identify PLOD1 as a diagnostic biomarker and TGF-β1-responsive profibrotic mediator in dupuytren’s disease
- Integrated network toxicology and experimental validation identify VCAM1 as a candidate molecular link between pyrethroid exposure and keloid
- Synergistic and antagonistic modulation of PI3K-Akt, MAPK, and NF-κB pathways by velvet antler in osteoporosis: an integrated network pharmacology, single-cell transcriptomic, and experimental validation study
- Identification of Endoplasmic reticulum Homeostasis-associated diagnostic biomarkers for Sarcopenia through integrated Bioinformatics and Experimental Validation
- Integrated toxicogenomic and single-nucleus transcriptomic analyses prioritize SDHB and NDUFAB1 in mitochondrial respiration-associated remodeling during cisplatin-induced acute kidney injury
BibTeX
@article{li2026integrated,
title = {{Integrated Multi-Omics and Experimental Validation Identify a Spermidine-Responsive FREM1 Remodeling Program in Ischemic Heart Failure}},
author = {Daisong Li and Yulong Xiong and Chenxi Ren and Jing Luo and Likun Zhou and Mengtong Xu and Boning Zhou and Beizheng Xu and Ligang Ding and Lihui Zheng and Yan Yao},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210267},
url = {https://www.mdpi.com/1422-0067/27/22/10267},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Integrated Multi-Omics and Experimental Validation Identify a Spermidine-Responsive FREM1 Remodeling Program in Ischemic Heart Failure
AU - Daisong Li
AU - Yulong Xiong
AU - Chenxi Ren
AU - Jing Luo
AU - Likun Zhou
AU - Mengtong Xu
AU - Boning Zhou
AU - Beizheng Xu
AU - Ligang Ding
AU - Lihui Zheng
AU - Yan Yao
PY - 2026
DA - 2026/11/16
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210267
UR - https://www.mdpi.com/1422-0067/27/22/10267
AB - Ischemic injury drives a sustained myocardial response in which metabolic stress, fibroblast activation, and extracellular-matrix remodeling converge to cause heart failure, yet the cell-resolved programs linking polyamine homeostasis to post-ischemic remodeling and the response to spermidine remain unclear. In this study, we integrated disease-burden estimates with bulk and single-nucleus myocardial transcriptomics, prioritizing polyamine-related genes by differential-expression analysis, gene-set scoring, and machine learning, followed by pathway, immune, cell–cell communication, and regulatory-network analyses, and evaluated spermidine in a post-myocardial-infarction mouse model using 8-week-old male C57BL/6J mice, with fibroblast-directed FREM1 activation to test whether FREM1 modifies the treatment response. Cross-platform analysis identified FREM1, MYH6, ARRDC3, and XAF1 as reproducible components of the ischemic-failing-heart signature, with FREM1 showing the strongest discrimination in the independent cohort; the program localized predominantly to fibroblasts and was linked to extracellular-matrix, inflammatory, and intercellular-signaling states. In mice, spermidine improved systolic function, reduced collagen deposition, shifted MTA and ornithine signals toward the sham pattern, and lowered myocardial FREM1; FREM1 activation weakened these effects, though residual benefit remained. These findings identify a fibroblast-enriched, spermidine-responsive FREM1 remodeling program linking polyamine-associated stress to post-ischemic fibrosis, positioning FREM1 as a candidate regulator of the cardiac response to spermidine and a potential entry point for therapeutic stratification in ischemic heart failure.
SN - 1422-0067
ER -